Mehmet Kazgan, Founder and CEO of cliexa, joins Avrohom Gottheil on #AskTheCEO to discuss what is missing in healthcare AI today: clinical reasoning. We explore how cliexaAI — trained on 12M+ real patient data points over nine years and qualified on Mayo Clinic Platform — predicts risk, reduces opioid prescriptions, and helps clinicians make informed decisions at the point of care.

Topics covered:

00:00 Introduction

00:46 The gap in healthcare AI today — clinical reasoning

02:57 Why proactive opioid risk prediction matters

05:25 How cliexaAI provides risk factors alongside predictions

06:46 Why custom-trained models outperform general-purpose AI

09:39 Closed-loop datasets vs publicly trained models

13:08 Mayo Clinic Platform qualification — three years of validation

15:51 How cliexaAI works — containerized, behind the EMR

17:55 Human in the loop explained

25:04 Nine years of building — from smart intake to clinical intelligence

27:02 Beyond OUD — cardiovascular, chronic kidney disease, eating disorders

34:21 Real-world results: 35% decline in opioid Rx, 272% revenue increase

37:13 Third scientific paper approved by International Journal of Eating Disorders

39:15 Responsible AI — ethical, unbiased, clinically safe

41:10 Why healthcare leaders should pay attention now

44:03 Summarizing cliexaAI in one sentence

45:07 Parting words of wisdom

Learn more about cliexa:

Email: [email protected]

Web: https://cliexa.com

Connect with Mehmet: https://www.linkedin.com/in/mehmetkazgan/

Learn more about AskTheCEO Media:

Web: https://asktheceo.io

Watch this episode on YouTube: https://youtu.be/eVJaFsAYJNo